Home › Cardiovascular Disease › Kansas
Cardiovascular Disease clinical trials in Kansas
18 studies for Cardiovascular Disease are looking for participants at sites in Kansas.
Cities in Kansas
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- AMR El Dorado, El Dorado
- Cotton O'Neil Diabetes & Endocrinology Center, Topeka
- Tekton Research - Wichita, Wichita
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Midwest Heart and Vascular Specialists, Overland Park
- Kansas Nephrology Physicians, PA, Wichita
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Hutchinson
- Clinical Trial Site, Kansas City
- Clinical Trial Site, Topeka
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109Product Surveillance Registry
- Kansas City
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- University of Kansas Medical Center, Kansas City
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- The University Of Kansas Medical Center, Kansas City
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- University of Kansas Hospital, Kansas City
- Cotton O Neil Clinical Res Center, Topeka
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kansas City
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- University of Kansas Medical Center, Kansas City
- VA Eastern Kansas Healthcare System, Topeka
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Kansas City
- Research Site, Kansas City
- Research Site, Topeka
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Hutchinson Clinic PA, Hutchinson
- University of Kansas Medical Center, Kansas City
- Midwest Heart and Vascular Specialists, Overland Park
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012Global Paradise System US Post Approval Study
- Ascension via Christi St. Francis, Wichita
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06297291ELEVATE-HFpEF Clinical Study
- University of Kansas Medical Center, Kansas City
Recruiting
Ages 40 and older · All sexes · Updated Aug 3, 2026 · NCT06678841The Oxford Risk Factors And Non-Invasive Imaging Study
- Midwest Heart & Vascular Specialists LLC, Kansas City
- St Luke's Hospital, Kansas City
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Jul 31, 2026 · NCT05169333PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- University of Kansas Medical Center (KUMC), Kansas City
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Kansas University Medical Center, Kansas City
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
- Midwest Heart and Vascular Specialists, Overland Park
RecruitingPhase 3
Ages 35 to 80 · All sexes · Updated Apr 16, 2026 · NCT07293260Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1/2
Ages 35 to 65 · All sexes · Updated Jun 8, 2025 · NCT04715022From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.